Mereo Biopharma 4 Limited opposition analysis

COMPANY ANALYSIS

Latest patents of Mereo Biopharma 4 Limited opposed by its competitors

Patent:
Grant Date:
Aug 23, 2023
Title:
Methods Involving Neutrophil Elastase Inhibitor Alvelestat For Treating Respiratory Disease Mediated By Alpha-1 Antitrypsin Deficiency
Oppositions:
1

Competitors of Mereo Biopharma 4 Limited

ELKINGTON AND FIFE LLP

Want to track Mereo Biopharma 4 Limited?

Feel free to send us a message here and we will get back to you